Jun 30, 2019

ANI Pharmaceuticals Q2 2019 Earnings Report

Total Revenue
$54.4M
Previous year: $47.3M
+15.0%
EPS
$1.44
Previous year: $1.13
+27.4%
Gross Profit
$38.7M
Previous year: $30.7M
+26.2%
Cash and Equivalents
$40.6M
Previous year: $55M
-26.2%
Free Cash Flow
$3.11M
Previous year: $7.51M
-58.6%
Total Assets
$447M
Previous year: $424M
+5.4%

ANI Pharmaceuticals

ANI Pharmaceuticals

ANI Pharmaceuticals Revenue by Segment

Revenue & Expenses

Visualization of income flow from segment revenue to net income